These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20608598)

  • 1. Current controversies in bisphosphonate therapy.
    Paul GR
    Orthopedics; 2010 Jul; 33(7):468. PubMed ID: 20608598
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate actions: physical chemistry revisited.
    Papapoulos SE
    Bone; 2006 May; 38(5):613-6. PubMed ID: 16504613
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental results of combining bisphosphonates with allograft in a rat model.
    Agholme F; Aspenberg P
    J Bone Joint Surg Br; 2009 May; 91(5):670-5. PubMed ID: 19407306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior bisphosphonate therapy of osteoporosis attenuates and blocks response to subsequent parathyroid hormone.
    Handler RP
    J Clin Rheumatol; 2008 Apr; 14(2):122-4. PubMed ID: 18391687
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic zoledronate precoating of a bone graft reduces bone resorption during remodeling.
    Tägil M; Aspenberg P; Astrand J
    Acta Orthop; 2006 Feb; 77(1):23-6. PubMed ID: 16534698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone loss prevention in cancer: new developments and perspectives.
    Lipton A
    Semin Oncol; 2010 Jun; 37 Suppl 1():S1-2. PubMed ID: 20682366
    [No Abstract]   [Full Text] [Related]  

  • 7. A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats.
    Gasser JA; Green JR; Shen V; Ingold P; Rebmann A; Bhatnagar AS; Evans DB
    Bone; 2006 Oct; 39(4):787-95. PubMed ID: 16844441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates: pharmacology and effects on the growing skeleton.
    Papapoulos SE
    Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
    [No Abstract]   [Full Text] [Related]  

  • 10. Microgravity and drug effects on bone.
    Shapiro JR
    J Musculoskelet Neuronal Interact; 2006; 6(4):322-3. PubMed ID: 17185807
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological effects of tiludronate in horses after long-term immobilization.
    Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
    Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats.
    Mastaglia SR; Pellegrini GG; Mandalunis PM; Gonzales Chaves MM; Friedman SM; Zeni SN
    Bone; 2006 Oct; 39(4):837-44. PubMed ID: 16765665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel bone-targeted strategies in oncology.
    Vallet S; Smith MR; Raje N
    Clin Cancer Res; 2010 Aug; 16(16):4084-93. PubMed ID: 20643782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.
    Bolland MJ; Grey AB; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Callon KE; Gamble GD; Reid IR
    J Bone Miner Res; 2008 Aug; 23(8):1304-8. PubMed ID: 18627266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of SERMs on bone health. The effects of raloxifene on bone quality evaluated by hip structure analysis].
    Takada J; Iba K; Yamashita T; Yoshizaki T
    Clin Calcium; 2010 Mar; 20(3):355-63. PubMed ID: 20190365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All bisphosphonates are (or may not be) the same: potential reasons for clinical differences.
    Miller PD
    J Womens Health (Larchmt); 2010 Apr; 19(4):665-9. PubMed ID: 20415640
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonate medications--the good, the bad, and the ugly.
    Bourgeois SL
    Tex Dent J; 2009 Jul; 126(7):596-604. PubMed ID: 19753815
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone morphology in response to alendronate as seen by high-resolution computed tomography: Through a glass darkly.
    Seeman E
    J Bone Miner Res; 2010 Dec; 25(12):2553-7. PubMed ID: 20928873
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of denosumab on the growing skeleton in osteogenesis imperfecta.
    Hoyer-Kuhn H; Semler O; Schoenau E
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3954-5. PubMed ID: 25148238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.